Merson Michael R 4
4 · AspenBio Pharma, Inc. · Filed Aug 5, 2009
Insider Transaction Report
Form 4
Merson Michael R
Director
Transactions
- Purchase
Common Stock
2009-07-31$2.80/sh+800$2,240→ 4,300 total
Holdings
- 50,000
Stock Options
Exercise: $1.33From: 2009-01-27Exp: 2019-01-27→ Common Stock (50,000 underlying) - 50,000
Stock Options
Exercise: $6.38From: 2008-07-01Exp: 2018-06-30→ Common Stock (50,000 underlying) - 15,674
Stock Options
Exercise: $6.38From: 2008-07-01Exp: 2018-06-30→ Common Stock (15,674 underlying)
Footnotes (1)
- [F1]These options were granted pursuant to the Company's 2002 Stock Incentive Plan. One-third of the options vest each year for three years following the date of grant. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).